Conflicting data. Multiple clinical trials have found no increase in risk of bleeding with antiplatelet or anticoagulant drugs, however there are some studies that suggest an interaction, particularly at higher doses

Clinical evaluation by a healthcare professional is recommended to assess the degree of intervention required

Anticoagulant and antiplatelet agents

Meta-analyses in patients with hypertension showed that 2-3 g daily of EPA+DHA significantly lowers systolic and diastolic blood pressure.

Evidence suggests this interaction is likely to occur in most patients

Intervention by a healthcare professional may be required

Omega-3 (EPA + DHA)